IL18 and systemic-onset juvenile idiopathic arthritis: A human recombinant form (Tradekinig Alfa, AB2 Bioltd) is currently under evaluation in treatment of Still's disease and hemophagocytic lymphohistiocytosis syndrome, that is to say a pathology in which the IL-18/IL-18R axis seems preponderant.